Ruth Wilson's journey with lupus has been a fight filled with pain, confusion, and ultimately advocacy. For six years, she encountered misdiagnoses and dismissals from healthcare professionals as her symptoms — including rashes, swelling, and severe pain — went unexplained. It wasn't until Wilson insisted on a urine test during her emergency room visit that her failing kidneys prompted the discovery of lupus, an illness described as the disease of 1,000 faces due to its varied symptoms.

I just wish there was a better way that patients could get that diagnosis without having to go through all of the pain and all of, like, the dismissiveness and the gaslighting, she remarked, reflecting on her experience.

Lupus is among numerous autoimmune diseases that collectively affect as many as 50 million Americans and millions more globally. Scientists are now exploring the biological underpinnings of these conditions, hoping to develop treatments that target causes rather than just symptoms.

As researchers draw connections between different autoimmune diseases, clinical trials are underway to harness patients' own immune cells to combat their overactive systems. Therapies like CAR-T have shown promise for lupus patients.

Meanwhile, Wilson balances her role as a patient with her commitment to educating others about lupus. She participates in community discussions and studies that highlight the importance of patient narratives in treatment efficacy, sharing that removing the stigma around autoimmune conditions starts with open dialogue and patient empowerment.

It’s important for me to also be a voice for patients because I think of myself and how lonely I was at the very beginning, she stated. This sentiment drives her participation in public forums and research, aiming to reshape perceptions of lupus and autoimmune diseases.